Skip to main content
OpenTrials
Completed

NCT Number: NCT00761748

Comparison of Two Urostomy Bags (2-piece).

Coloplast A/S has developed a new, improved 2-piece product for people with urostomies.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Visé Mitteldeutschland GmbH

Magdeburg, 39114, Germany

About this study

The 2-piece product is a part of a new product family, under the brand name SenSura. The aim of this investigation is to see how the urology product is perceived and how it performs against another 2-piece product from ConvaTec. The device 'ConvaTec 2-piece combihesive Natura' is selected as the comparative product because of its similarity to SenSura 2-piece product.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Be at least 18 years old,
  • Be able to complete a written consent form
  • Be able to fill in the Case Report Form
  • Have a urostomy with a diameter of 33 mm. or less.
  • Have had the urostomy for 3 months or more.
  • Use a 2-piece convex (or convex light) normally.
  • Be able to use SenSura URO 2-piece product
  • Be able to use ConvaTec, 2-piece product
  • Be able to handle the product themselves (application, removal and emptying),

Exclusion criteria

  • In order to be enrolled in the clinical investigation, the subjects must not:
  • Need to use an ostomy belt
  • Be currently suffering from any dermatological problems, needing special treatment, on the peristomal skin
  • Being treated with chemo- or radiation therapy,
  • Be hospitalized during study enrollment, or have a hospitalization or significant surgery planned during the 4-week study period, or
  • Be pregnant or breast-feeding.

Treatment and study plan

Convatec Uro 2-piece

Device

Specific name of the device: 'Combihesive Natura® with a Durahesive Convex-It® base plate, 45 mm coupling, moldable (13-22 and 22-33 mm) hole size with boarder tape'.

The subjects are asked to test each of the two products for 21 days plus/minus 3 days in a randomised order and in accordance with their normal frequency of change and normal use pattern. The duration of the clinical investigation should be enough time to identify any difference in user-preference. If the subject is in the middle of testing an urostomy base plate when the test period is turning into the next period, the urostomy base plate can be worn until it needs to be changed. It is not possible to blind the investigation as the appearance of the test- and refer-ence products are very different in the look.

Other names: ConvaTec 2-piece

SenSura Uro 2-piece

Device

SenSura URO 2-piece Extended Wear, convex light, 50 mm coupling, cuttable (15-33 mm)

Other names: SenSura

Primary outcomes

  1. Preference of the Two Urostomy Products

    Time frame: 6 weeks

    Number of participants preferring the SenSura Uro 2 piece product or the reference Convatec 2 piece product.

    The subjects are asked via the case report form (questionnaire) at the end of the second cross over period, which of the two products they preferred.

Sponsors and collaborators

Lead sponsor

Coloplast A/S

Industry

Registry information

Official study title

A Comparative, Randomised, Crossover Study With SenSura Uro 2-piece Versus ConvaTec 2-piece Among 30 Urostomy-operated Persons in Germany

Important dates

Study start
2008
Primary completion
2009
Study completion
2009
First posted
Sep 29, 2008
Registry last updated
Jan 1, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.